Myrbetriq (mirabegron)

**Product type:** Human Prescription Drug

**Active ingredient:** MIRABEGRON

**Strength:** 25 mg/1

**Dosage form:** Tablet, Film Coated, Extended Release

**Route:** Oral

**Labeler:** Astellas Pharma US, Inc.

**Marketing category:** NDA (NDA202611)

**Pharmacologic class:** Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]